2024-10-22 - CD Munich - Amgen v. Sanofi et al. - UPC_CFI_14/2023

Aktenzeichen:
UPC_CFI_14/2023
Datum:
Spruchkörper:
Court of First Instance - Munich (DE) Central Division - Section
Art:
Application Order
Parteien:
Dehns v. Regeneron, Amgen

Kernaussage: 262.

2024-10-22 - CD Munich - Amgen v. Sanofi et al. - UPC_CFI_14/2023
🏛️Court of First Instance - Munich (DE) Central Division - Section• Application Order
📅2024-10-22
🔢UPC_CFI_14/2023
Parteien & Vertreter
Kläger / Berufungsführer
Amgen Inc.
Johannes HESELBERGER
Beklagter / Berufungsbeklagter
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Groupe S.A.
Sanofi Winthrop Industrie S.A.
Regeneron Pharmaceuticals Inc.
Niels HOELDER
📋ORD_47235/2024
⚖️Application RoP262.1 (b)
🌐English

262.1(b) application. Access to written pleadings and evidence. Other documents.

The Munich Central Division granted file access to the applicant, stating that there is a general interests in making pleadings and evidence publically available. However, other documents were not covered by 262. This is one of three parallel orders in this litigation complex.
Stichwörter
Access to written pleadings and evidence, 262.1(b) application

Entscheidung teilen

Weitere Navigation
Entscheidungen
Rechtstexte
Analysen

Zu Sammlung hinzufügen

0 Einträge hinzufügen zu:

Anmeldung

Registrieren